Literature DB >> 15095005

Where, when and how much: regulation of myelin proteolipid protein gene expression.

P A Wight1, A Dobretsova.   

Abstract

The myelin proteolipid protein (PLP) gene ( Plp) encodes the most abundant protein found in myelin from the central nervous system (CNS). Expression of the gene is regulated in a spatiotemporal manner with maximal levels of expression occurring in oligodendrocytes during the active myelination period of CNS development, although other cell types in the CNS as well as in the periphery can express the gene to a much lower degree. In oligodendrocytes, Plp gene expression is tightly regulated. Underexpression or overexpression of the gene has been shown to have adverse effects in humans and other vertebrates. In light of this strict control, this review provides an overview of the current knowledge of Plp gene regulation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15095005     DOI: 10.1007/s00018-003-3309-z

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  55 in total

1.  Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection.

Authors:  Susan Stewart; Gayle L Winters; Michael C Fishbein; Henry D Tazelaar; Jon Kobashigawa; Jacki Abrams; Claus B Andersen; Annalisa Angelini; Gerald J Berry; Margaret M Burke; Anthony J Demetris; Elizabeth Hammond; Silviu Itescu; Charles C Marboe; Bruce McManus; Elaine F Reed; Nancy L Reinsmoen; E Rene Rodriguez; Alan G Rose; Marlene Rose; Nicole Suciu-Focia; Adriana Zeevi; Margaret E Billingham
Journal:  J Heart Lung Transplant       Date:  2005-06-20       Impact factor: 10.247

2.  Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report.

Authors:  J A Kobashigawa; L W Miller; S D Russell; G A Ewald; M J Zucker; L R Goldberg; H J Eisen; K Salm; D Tolzman; J Gao; W Fitzsimmons; R First
Journal:  Am J Transplant       Date:  2006-06       Impact factor: 8.086

3.  Procalcitonin, a new indicator for non-viral infections in heart, lung or liver transplant patients.

Authors:  S Hammer; P Fraunberger; B Meiser; M Stangl; D Seidel; C Hammer
Journal:  Ann Transplant       Date:  1999       Impact factor: 1.530

4.  Brain natriuretic peptide levels do not correlate with acute cellular rejection in De Novo orthotopic heart transplant recipients.

Authors:  James O O'Neill; Andrew T McRae; Richard W Troughton; Kenneth Ng; David O Taylor; Mohammed H Yamani; James B Young; Randall C Starling
Journal:  J Heart Lung Transplant       Date:  2005-04       Impact factor: 10.247

5.  Intramyocardial electrograms for the monitoring of allograft rejection after heart transplantation using spontaneous and paced beats.

Authors:  T Auer; G Schreier; H Hutten; K H Tscheliessnigg; T Allmayr; B Grasser; F Iberer; A Wasler; B Petutschnigg; H Müller
Journal:  Transplant Proc       Date:  1995-10       Impact factor: 1.066

6.  Quantitative monitoring of gene expression patterns with a complementary DNA microarray.

Authors:  M Schena; D Shalon; R W Davis; P O Brown
Journal:  Science       Date:  1995-10-20       Impact factor: 47.728

7.  Significance of raised natriuretic peptides after bicaval and standard cardiac transplantation.

Authors:  A El Gamel; N A Yonan; B Keevil; R Warbuton; J Kakadellis; A Woodcock; C S Campbell; A N Rahman; A K Deiraniya
Journal:  Ann Thorac Surg       Date:  1997-04       Impact factor: 4.330

8.  Predictive value of brain natriuretic peptide in the diagnosis of heart transplant rejection.

Authors:  Miguel A Arnau-Vives; Luis Almenar; Isabel Hervas; Ana Osa; Luis Martinez-Dolz; Joaquin Rueda; Esther Zorio; Luis Martinez-Ortiz De Urbina; Jose L Perez; Antonio Mateo; Miguel Palencia
Journal:  J Heart Lung Transplant       Date:  2004-07       Impact factor: 10.247

9.  Vasoactive peptides during long-term follow-up of patients after cardiac transplantation.

Authors:  Wiebke Ch Kirchhoff; Rainer Gradaus; Joerg Stypmann; Mario C Deng; Tonny D T Tian; Hans H Scheld; Günter Breithardt; Betty Brisse
Journal:  J Heart Lung Transplant       Date:  2004-03       Impact factor: 10.247

10.  Serial study of C reactive protein concentrations in cardiac allograft recipients.

Authors:  G D Harkiss
Journal:  J Clin Pathol       Date:  1985-02       Impact factor: 3.411

View more
  14 in total

1.  Microarray analysis identifies cerebellar genes sensitive to chronic ethanol treatment in PKCgamma mice.

Authors:  Barbara J Bowers; Richard A Radcliffe; Amy M Smith; Jill Miyamoto-Ditmon; Jeanne M Wehner
Journal:  Alcohol       Date:  2006-08       Impact factor: 2.405

2.  Expression of transcripts for myelin related genes in postmortem brain from cocaine abusers.

Authors:  Lars V Kristiansen; Michael J Bannon; James H Meador-Woodruff
Journal:  Neurochem Res       Date:  2008-03-21       Impact factor: 3.996

3.  CX3CL1/CX3CR1 Axis Plays a Key Role in Ischemia-Induced Oligodendrocyte Injury via p38MAPK Signaling Pathway.

Authors:  Xiao-Mei Wu; Yong Liu; Zhong-Ming Qian; Qian-Qian Luo; Ya Ke
Journal:  Mol Neurobiol       Date:  2015-07-20       Impact factor: 5.590

4.  The wmN1 enhancer region in intron 1 is required for expression of human PLP1.

Authors:  Hamdan Hamdan; Pankaj Patyal; Neriman T Kockara; Patricia A Wight
Journal:  Glia       Date:  2018-04-23       Impact factor: 7.452

5.  Expression of myelin genes: comparative analysis of Oli-neu and N20.1 oligodendroglial cell lines.

Authors:  Glauber B Pereira; Anna Dobretsova; Hamdan Hamdan; Patricia A Wight
Journal:  J Neurosci Res       Date:  2011-04-06       Impact factor: 4.164

6.  Leydig cells express the myelin proteolipid protein gene and incorporate a new alternatively spliced exon.

Authors:  Shenyang Li; Brian T Greuel; Fanxue Meng; Glauber B Pereira; Adria Pitts; Anna Dobretsova; Patricia A Wight
Journal:  Gene       Date:  2009-02-13       Impact factor: 3.688

7.  Targeted deletion of the antisilencer/enhancer (ASE) element from intron 1 of the myelin proteolipid protein gene (Plp1) in mouse reveals that the element is dispensable for Plp1 expression in brain during development and remyelination.

Authors:  Glauber B Pereira; Fanxue Meng; Neriman T Kockara; Baoli Yang; Patricia A Wight
Journal:  J Neurochem       Date:  2012-12-21       Impact factor: 5.372

8.  Histone deacetylase 11 regulates oligodendrocyte-specific gene expression and cell development in OL-1 oligodendroglia cells.

Authors:  Hedi Liu; Qichen Hu; A Joseph D'ercole; Ping Ye
Journal:  Glia       Date:  2009-01-01       Impact factor: 7.452

9.  Gait abnormalities and progressive myelin degeneration in a new murine model of Pelizaeus-Merzbacher disease with tandem genomic duplication.

Authors:  Kristi Clark; Lauren Sakowski; Karen Sperle; Linda Banser; Carlisle P Landel; Denise A Bessert; Robert P Skoff; Grace M Hobson
Journal:  J Neurosci       Date:  2013-07-17       Impact factor: 6.167

10.  Myelin antigen load influences antigen presentation and severity of central nervous system autoimmunity.

Authors:  Ritika Jaini; Daniela C Popescu; Chris A Flask; Wendy B Macklin; Vincent K Tuohy
Journal:  J Neuroimmunol       Date:  2013-04-17       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.